ArticleKidney international reports2025
Response To the Letter to the Editor Entitled "First Report of Daratumumab Therapy in Refractory THSD7A-Positive Membranous Nephropathy".
Fatima Ayub et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.